Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Lexaria Bioscience Corp. (LEXX)

3.29   0.22 (7.17%) 06-26 22:24
Open: 2.99 Pre. Close: 3.07
High: 3.29 Low: 2.9682
Volume: 30,451 Market Cap: 20(M)
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and in some instances with cannabinoids by 27x compared to standard industry formulations, reduce time of onset from 1 - 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, and others. DehydraTECH also deliver drugs effectively across the blood brain barrier. It operates a licensed in-house research laboratory and holds intellectual property portfolio with 23 patents granted and approximately 50 patents pending worldwide. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.29 - 3.3 3.3 - 3.31
Low: 2.94 - 2.95 2.95 - 2.96
Close: 3.27 - 3.29 3.29 - 3.31

Technical analysis

as of: 2022-06-24 4:41:21 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 3.84     One year: 4.48
Support: Support1: 2.4    Support2: 1.85
Resistance: Resistance1: 3.28    Resistance2: 3.84
Pivot: 2.46
Moving Average: MA(5): 2.87     MA(20): 2.38
MA(100): 2.96     MA(250): 4.65
MACD: MACD(12,26): 0.1     Signal(9): 0
Stochastic oscillator: %K(14,3): 94.3     %D(3): 86.8
RSI: RSI(14): 76
52-week: High: 12.5  Low: 1.85
Average Vol(K): 3-Month: 955 (K)  10-Days: 50 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ LEXX ] has closed above the upper band by 9.3%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 52.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

Headline News

Fri, 24 Jun 2022
Guildford Fringe Festival and New Cabaret Venue The Fallen Angel Open in Guildford This Weekend - Broadway World

Tue, 21 Jun 2022
Lexaria's (NASDAQ: LEXX) Studies Opening 'Doors Previously Closed to Disruptive New Technology' - Digital Journal

Fri, 17 Jun 2022
BBC offers free comedy workshops : Other news 2022 - Chortle

Thu, 16 Jun 2022
Short Interest in Lexaria Bioscience Corp. (NASDAQ:LEXX) Rises By 34.1% - Defense World

Tue, 14 Jun 2022
Lexaria Bioscience (NASDAQ: LEXX) and the Budding Alternative Nicotine Market - Digital Journal

Mon, 13 Jun 2022
LEXX: Global Deals Take Center Stage - Benzinga - Benzinga

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 6 (M)
% Held by Insiders 4.54e+006 (%)
% Held by Institutions 17.6 (%)
Shares Short 266 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -7.21e+006
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -2
Return on Assets (ttm) 618.4
Return on Equity (ttm) -38.8
Qtrly Rev. Growth 279610
Gross Profit (p.s.) -48
Sales Per Share -36.51
EBITDA (p.s.) 312794
Qtrly Earnings Growth -1
Operating Cash Flow 0 (M)
Levered Free Cash Flow -5 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.1
Price to Cash Flow 2.48

Stock Dividends

Dividend 0
Forward Dividend 297280
Dividend Yield 0%
Dividend Pay Date 2021-01-11
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.